Flush with cash and data, 23andMe aims to push its first drug into the clinic early next year

"We're putting our back into it," an executive said after the company made its first quarterly report since going public in June.

Article by [author-name] (c) Health Care News - Health Care News Headlines | Bizjournals.com - Read full story here.